Substituted piperidine compounds and methods of their use

Details for Australian Patent Application No. 2004249178 (hide)

Owner Adolor Corporation

Inventors Dolle, Roland E.; Le Bourdonnec, Bertrand

Agent Watermark

Pub. Number AU-B-2004249178

PCT Pub. Number WO2004/112704

Priority 10/462,507 16.06.03 US

Filing date 15 June 2004

Wipo publication date 29 December 2004

Acceptance publication date 31 March 2011

International Classifications

C07D 211/22 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07F 9/59 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2004/112704 Priority application(s): WO2004/112704

31 March 2011 Application Accepted

  Published as AU-B-2004249178

28 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249181-Vascular clamp

2004249172-Specific delivery of drugs to the brain